A detailed history of Point72 (Difc) LTD transactions in Geron Corp stock. As of the latest transaction made, Point72 (Difc) LTD holds 259,053 shares of GERN stock, worth $404,122. This represents 0.02% of its overall portfolio holdings.

Number of Shares
259,053
Previous 31,133 732.08%
Holding current value
$404,122
Previous $110 Million 273.73%
% of portfolio
0.02%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$1.59 - $3.6 $362,392 - $820,512
227,920 Added 732.08%
259,053 $412 Million
Q4 2024

Feb 14, 2025

BUY
$3.3 - $4.44 $102,738 - $138,230
31,133 New
31,133 $110 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $589M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.